Patents Assigned to Tasrif Pharmaceutical, LLC
  • Antibodies and antibody fragments against the CD155 receptor and methods of use thereof
    Patent number: 11098130
    Abstract: A humanized antibody to the poliovirus receptor can be used to target nucleic acids, proteins, and chemicals to brain cancer cells, thus providing treatment for tumors that are otherwise hard to treat due to the difficulty of getting treatments through the blood brain barrier.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: August 24, 2021
    Assignee: Tasrif Pharmaceutical, LLC
    Inventors: Aftab S. Karim, Robert Holgate, Arron Hearn